M. Fonck

发表

Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in second and third-line treatment of metastatic colorectal cancer (mCRC): Safety and efficacy analysis.

D. Smith, Y. Bécouarn, J. Blanc, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The tumor burden of metastatic colorectal cancer patients at initial diagnosis, pre- versus post-Covid-19 lockdown

M. Ychou, E. Assenat, D. Smith, 2021, medRxiv.

KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications

I. Soubeyran, A. Italiano, Y. Bécouarn, 2010, Annals of Surgical Oncology.

Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM).

P. Ruszniewski, P. Hammel, F. Selle, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Fatal Acute Liver Failure as a Consequence of Regorafenib Treatment in a Metastatic Colon Cancer

P. Bernard, C. Castain, M. Desjardin, 2017, Case Reports in Oncology.

Single-Session Radiofrequency Ablation of Bilateral Lung Metastases

V. Brouste, A. Avril, S. Ferron, 2012, CardioVascular and Interventional Radiology.

Diagnostic accuracy and clinical impact of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in Positron Emission Tomography - Computed Tomography (PET-CT)-positive mediastinal lymphadenopathies in subjects with thoracic or extra-thoracic malignancy.

I. Soubeyran, C. Bellera, M. Debled, 2022, Clinics and research in hepatology and gastroenterology.

[Hepatotoxicity of tyrosine kinase inhibitors: Mechanisms involved and practical implications].

Y. Bécouarn, M. Desjardin, D. Béchade, 2018, Bulletin du cancer.

Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases

T. de Baère, T. Baère, B. Escudier, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al.

T. de Baère, B. Escudier, P. Chevallier, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False

V. Brouste, B. le Bail, Y. Bécouarn, 2019, Clinical Medicine Insights. Oncology.

Cytoreductive Surgery of Colorectal Peritoneal Metastases: Outcomes after Complete Cytoreductive Surgery and Systemic Chemotherapy Only

V. Brouste, Y. Bécouarn, S. Evrard, 2015, PloS one.

Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases.

S. Mathoulin-Pélissier, F. Leblanc, Y. Bécouarn, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection

S. Mathoulin-Pélissier, Y. Bécouarn, C. Bellera, 2012, The British journal of surgery.

[Regenerative nodular hyperplasia of the liver related to oxaliplatin-based chemotherapy].

I. Soubeyran, Y. Bécouarn, S. Evrard, 2013, Presse medicale.

Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial.

Y. Bécouarn, R. Brunet, M. Fonck, 1998, American journal of clinical oncology.

Gemcitabine in combination with cisplatin (GP) versus gemcitabine (G) alone in the treatment of locally advanced or metastatic pancreatic cancer: Final results of a multicenter randomized phase II study.

M. Ychou, L. Mineur, F. Viret, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pancreatic Acinar Cell Carcinoma

Y. Bécouarn, S. Evrard, G. Désolneux, 2016, Case Reports in Gastroenterology.

6011 ORAL Unresectable Colorectal Liver Metastases Treated by Intraoperative Radiofrequency Ablation With or Without Resection: the ARF2003 Study

S. Mathoulin-Pélissier, Y. Bécouarn, C. Bellera, 2011 .

Screening older cancer patients: first evaluation of the G-8 geriatric screening tool.

S. Mathoulin-Pélissier, F. Delva, C. Bellera, 2012 .

Treatment of hepatitis C virus–related cirrhosis: A randomized, controlled trial of interferon alfa‐2b versus no treatment

P. Marcellin, M. Chevallier, D. Valla, 1999, Hepatology.

State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases.

C. Bréchot, G. Vyas, M. Hadchouel, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts

S. Mathoulin-Pélissier, E. Brain, C. Bellera, 2021, Cancers.

Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation

X. Buy, A. Crombé, J. Palussiere, 2021, European Radiology.

Undernutrition in elderly patients with cancer: target for diagnosis and intervention.

I. Bourdel-Marchasson, M. Rainfray, P. Soubeyran, 2008, Critical reviews in oncology/hematology.

Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial

M. Ychou, E. Assenat, R. Guimbaud, 2022, British Journal of Cancer.

Screening older cancer patients: first evaluation of the G-8 geriatric screening tool.

S. Mathoulin-Pélissier, F. Delva, C. Bellera, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Predictive factors of depressive symptoms of elderly patients with cancer receiving first‐line chemotherapy

V. Brouste, S. Mathoulin-Pélissier, M. Rainfray, 2017, Psycho-oncology.

Could bipolar vessel sealers prevent bile leaks after hepatectomy?

S. Mathoulin-Pélissier, Y. Bécouarn, S. Evrard, 2006, Langenbeck's Archives of Surgery.

Functional decline in older patients with cancer receiving first-line chemotherapy.

A. Ravaud, S. Mathoulin-Pélissier, A. Floquet, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of early death risk in older patients treated with first-line chemotherapy for cancer.

A. Ravaud, V. Brouste, A. Floquet, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of a screening test for elderly patients in oncology

S. Mathoulin-Pélissier, C. Bellera, M. Rainfray, 2008 .

Effects of a physical activity programme to prevent physical performance decline in onco‐geriatric patients: a randomized multicentre trial

J. Durrieu, I. Bourdel-Marchasson, R. Thiébaut, 2019, Journal of cachexia, sarcopenia and muscle.

433P Durvalumab and tremelimumab in combination with FOLFOX in patients with previously untreated RAS-mutated metastatic colorectal cancer: First results of efficacy at one year for phase II MEDITREME trial

C. Borg, A. Bertaut, Jean-David Fumet, 2021, Annals of Oncology.

Parenchymal sparing surgery for colorectal liver metastases: The need for a common definition.

V. Brouste, Y. Bécouarn, S. Evrard, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II study.

S. Mathoulin-Pélissier, Y. Bécouarn, C. Bellera, 2011, Clinics and research in hepatology and gastroenterology.

Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer

M. Ychou, E. Assenat, D. Botsen, 2021, JAMA network open.

FOLFIRI® and Bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms

S. Mathoulin-Pélissier, Y. Bécouarn, J. Robert, 2014, BMC Research Notes.

FOLFIRI® and Bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms

S. Mathoulin-Pélissier, Y. Bécouarn, J. Robert, 2014, BMC Research Notes.

Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study

M. Ychou, J. Daurès, E. Assenat, 2021, Cancers.

Durvalumab and tremelimumab in combination with FOLFOX in patients with RAS-mutated, microsatellite-stable, previously untreated metastatic colorectal cancer (MCRC): Results of the first intermediate analysis of the phase Ib/II MEDETREME trial.

C. Borg, Jean-David Fumet, F. Ghiringhelli, 2020 .